Hideaki Miyake

Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial

Marine Gross‐Goupil, Tae‐Geon Kwon, Masatoshi Eto et al. · Annals of Oncology · 2018 · 252 citations · Full text

Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.

Hideaki Miyake, Colleen C. Nelson, Paul S. Rennie et al. · PubMed · 2000 · 223 citations

Urology, Antiapoptotic Gene, Genetics +15

Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.

Chuang C. Chiueh, Hideaki Miyake, M.T. Peng · PubMed · 1993 · 176 citations

Medicine, Mptp-induced Parkinsonism, Neurotransmitter +9

Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.

Martin Gleave, Anthony W. Tolcher, Hideaki Miyake et al. · QUT ePrints (Queensland University of Technology) · 1999 · 174 citations · Full text

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

Hideaki Miyake, Isao Hara, Kazuki Yamanaka et al. · The Prostate · 1999 · 159 citations